BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4208713)

  • 1. Differential analysis of cyclocytidine, 1-beta-D-arabinofuranosylcytosine, and 1-beta-D-arabinofuranosyluracil by ultraviolet spectophotometry.
    Furner RL; Gaston RW; Strobel JD; el-Dareer S; Mellett LB
    J Natl Cancer Inst; 1974 May; 52(5):1521-8. PubMed ID: 4208713
    [No Abstract]   [Full Text] [Related]  

  • 2. Distribution and excretion of cyclocytidine in monkeys, dogs, and rats.
    Hirayama H; Sugihara T; Hamada F; Kanai T; Hikita J
    Gan; 1974 Apr; 65(2):153-61. PubMed ID: 4209835
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical pharmacology of 1-beta-d-arabinofuranosyl cytosine.
    Ho DH; Frei E
    Clin Pharmacol Ther; 1971; 12(6):944-54. PubMed ID: 5289712
    [No Abstract]   [Full Text] [Related]  

  • 4. Preparation and properties of O'-methyl and O'-ethyl derivatives of 1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosyluracil.
    Darzynkiewicz E; Shugar D
    Acta Biochim Pol; 1974; 21(3):305-22. PubMed ID: 4440349
    [No Abstract]   [Full Text] [Related]  

  • 5. A radioimmunoassay method for 1-beta-D-arabinofuranosyluracil using antibodies directed against 1-beta-D-arabinofuranosylcytosine.
    Okabayashi T; Mihara S; Moffatt JG
    Cancer Res; 1977 Feb; 37(2):625-8. PubMed ID: 12864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A radioimmunoassay for 1-beta-D-arabinofuranosylcytosine.
    Okabayashi T; Mihara S; Repke DB; Moffatt JG
    Cancer Res; 1977 Feb; 37(2):619-24. PubMed ID: 832282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A radioimmunoassay for 1-beta-D-arabinofuranosyluracil with reference to cross-reactivity of 1-beta-D-arabinofuranosylcytosine with an antibody.
    Okabayashi T; Mihara S; Repke DB; Moffatt JG
    Cancer Res; 1977 Sep; 37(9):3132-5. PubMed ID: 18280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatographic analysis (TLC) of uracil arabinoside, cytosine arabinoside, uracil and cytosine in human plasma.
    Paw B; Misztal G
    Acta Pol Pharm; 1995; 52(6):455-7. PubMed ID: 8960263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous analysis of 1-beta-D-arabinofuranosylcytosine, 1-beta-D-arabinofuranosyluracil and sodium salicylate in biological samples by high-performance liquid chromatography.
    Liversidge GG; Nishihata T; Higuchi T; Shaffer R; Cortese M
    J Chromatogr; 1983 Sep; 276(2):375-83. PubMed ID: 6630386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatographic analysis of cytosine arabinoside and metabolites in biological samples.
    Pallavicini MG; Mazrimas JA
    J Chromatogr; 1980 Oct; 183(4):449-58. PubMed ID: 7430297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A microbiological assay for cyclocytidine--disposition studies in mice.
    Neil GL; Kuentzel SL; Berger AE
    Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):561-72. PubMed ID: 4633769
    [No Abstract]   [Full Text] [Related]  

  • 12. 5'-O-methyl derivatives of 1- -D-arabinofuranosylcytosine and 1- -D-arabinofuranosyluracil.
    Giziewicz J; Kuśmierek JT; Shugar D
    J Med Chem; 1972 Aug; 15(8):839-40. PubMed ID: 5044298
    [No Abstract]   [Full Text] [Related]  

  • 13. Ion-pair liquid chromatography of cytarabine and uracil-arabinoside in human plasma.
    Burk M; Volmer M; Fartash K; Schneider W
    Arzneimittelforschung; 1995 May; 45(5):616-9. PubMed ID: 7612064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of cyclocytidine and arabinosylcytosine disposition in rats.
    Novotný L; Farghali H; Janků I; Beránek J
    Neoplasma; 1988; 35(6):707-14. PubMed ID: 2464769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies in vitro on some precursors of 1- -D-arabinosylcytosine.
    Hayashikawa RH; Nagyvary J
    Biochem Pharmacol; 1973 Mar; 22(5):609-22. PubMed ID: 4692170
    [No Abstract]   [Full Text] [Related]  

  • 16. Distribution of [3H]cytosine arabinoside and its products in mice, dogs, and monkeys and effect of tetrahydrouridine.
    Dareer SM; Mulligan LT; White V; Tillery K; Mellett LB; Hill DL
    Cancer Treat Rep; 1977; 61(3):395-407. PubMed ID: 406044
    [No Abstract]   [Full Text] [Related]  

  • 17. Simultaneous determination of 1-β-d-Arabinofuranosylcytosine and two metabolites, 1-β-d-Arabinofuranosyluracil and 1-β-d-Arabinofuranosylcytosine triphosphate in leukemic cell by HPLC-MS/MS and the application to cell pharmacokinetics.
    Liang D; Wang W; Jiang X; Yin S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 962():14-19. PubMed ID: 24880220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates of formation of blood-borne uridine and cytidine in dogs.
    Tseng J; Barelkovski J; Gurpide E
    Am J Physiol; 1971 Sep; 221(3):869-78. PubMed ID: 5570345
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetics of effect of 1-beta-D-arabinofuranosylcytosine, its 5'-palmitoyl ester, 1-beta-D-arabinofuranosyluracil, and tritiated thymidine on the viability of cultured leukemia L1210 cells.
    Wilkoff LJ; Dulmadge EA; Lloyd HH
    J Natl Cancer Inst; 1972 Mar; 48(3):685-95. PubMed ID: 5058968
    [No Abstract]   [Full Text] [Related]  

  • 20. High-performance liquid chromatographic assay for cytosine arabinoside and uracil arabinoside in cerebrospinal fluid and plasma.
    Riccardi A; Servidei T; Lasorella A; Riccardi R
    J Chromatogr; 1989 Dec; 497():302-7. PubMed ID: 2625467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.